Huaizhu Wu (@hwubcm) header
Huaizhu Wu (@hwubcm) profile picture

Huaizhu Wu

@hwubcm

Professor of Medicine, Baylor College of Medicine. Cardiometabolic research on inflammation, metabolism, and atherosclerosis

 United States
Joined November 2019
  • Tweets28
  • Following92
  • Followers73
Group photo of the 15th CADA annual meeting in Orlando, FL! We are looking forward to more people joining us!
Image from Chinese American Diabetes Association (@CADA_diabetes)
6
1
26
1,750
One of the major goals of CADA is to help young researchers navigate the challenges of their early careers by offering mentorship, resources, and networking opportunities. This is a letter from an undergraduate student. Please spread out!
Image from Chinese American Diabetes Association (@CADA_diabetes)
9
20
2,202
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia | New England Journal of Medicine. Looking forwards to phase outcome study ⁦@BCMHouston_News⁩ ⁦@BCMHeart⁩ ⁦@Texas_Heart⁩ nejm.org/doi/full/10.1056/NE…
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia | NEJM

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia | NEJM

Persons with mixed hyperlipidemia are at risk for atherosclerotic cardiovascular disease due to an elevated non–high-density lipoprotein (HDL) cholesterol level, which is driven by remnant choleste...

nejm.org
5
21
873
Dietary Effects on Monocyte Phenotypes in Subjects With Hypertriglyceridemia and Metabolic Syndrome | JACC: Basic to Translational Science. Clinical study ⁦@hwubcm⁩ ⁦@BCM_CVRI⁩ Impact of high saturated fat diet on monocytes jacc.org/doi/10.1016/j.jacbt…
Dietary Effects on Monocyte Phenotypes in Subjects With Hypertriglyceridemia and Metabolic Syndrome:

Dietary Effects on Monocyte Phenotypes in Subjects With Hypertriglyceridemia and Metabolic Syndrome:

jacc.org
3
5
1
14
2,286
Excellent presentation ⁦@jia_xiaoming⁩ Finalist Elizabeth Barrett-Connor Award Early Career Investigator IL-6 more promising target than IL-18 in elderly ⁦@BCMHeart⁩ ⁦@BCM_CVRI⁩ ⁦@BCMDeptMedicine⁩ ⁦
Image from Christie Ballantyne (@CBallantyneMD)
2
6
30
Novel agents targeting Lp(a), triglycerides spearhead ‘profound change in therapies’. Very exciting times in the field of lipids with new approaches for targets identified by #genetics ⁦@nationallipid⁩ ⁦@BCMHeart⁩ ⁦@BCM_CVRI⁩ healio.com/news/cardiology/2…
Novel agents targeting Lp(a), triglycerides spearhead ‘profound change in therapies’

Novel agents targeting Lp(a), triglycerides spearhead ‘profound change in therapies’

Much research is being conducted on novel therapeutics to reduce residual lipid-related risks, a speaker said at the National Lipid Association Scientific Sessions.“It has never been a more exciting...

healio.com
1
2
24
ESC debate | Do patients benefit from omega-3 fatty acids? - PACE-CME Very nice summary of our #ESC debate on REDUCE-IT and STRENTH #EPA #DHA #omega3 pace-cme.org/2021/09/07/esc-…

ESC debate | Do patients benefit from omega-3 fatty acids?

Positioning of the topicNews - Sep. 7, 2021 Chairpersons: Prof. Magnus Back (Stockholm, Sweden) and prof. Ulrich Laufs (Leipzig, Germany) Magnus Back

pace-cme.org
1
4
11
Has the “strength” of fish oil therapy been “reduced”? reconciling the results of REDUCE-IT and STRENGTH academic.oup.com/ehjcvp/adva… @virani_md @vijay_nambi @BCMHeart @BCM_CVRI @BCMDeptMedicine @DLBHATTMD @mmillermd1 @alanbrownmd @lipiddoc
Has the ‘strength’ of fish oil therapy been ‘reduced’? Reconciling the results of REDUCE-IT and...

Has the ‘strength’ of fish oil therapy been ‘reduced’? Reconciling the results of REDUCE-IT and...

The disparate results of STRENGTH1 (stopped for futility) and REDUCE-IT2 (significantly reduced cardiovascular outcomes), despite similar triglyceride redu

academic.oup.com
9
24
Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study academic.oup.com/eurjpc/adva… @AlizaHussainMD @BCMHeart @LizSelvin @vijay_nambi
Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovasc...

Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovasc...

AbstractAims. Despite statin and antihypertensive therapies, older Americans have high atherosclerotic cardiovascular disease (ASCVD) risk. Novel measures

academic.oup.com
1
7
18
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation academic.oup.com/clinchem/ar… What tests should you order to assess residual risk after lowering #LDL-C #prevention #remnants #inflammation @ClinicalChemist
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation

Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation

AbstractBackground. Current guidelines target low-density lipoprotein cholesterol (LDL-C) concentrations to reduce atherosclerotic cardiovascular disease (

academic.oup.com
7
22
Dr. Christie M. Ballantyne discusses the topic of CVD prevention in the cardiometabolic patient in light of the recently released cholesterol and comprehensive primary prevention guidelines: cmhc.info/3iPZqlx #CMHC #hearthealth #heartdisease #cardiology @CBallantyneMD
Image from Cardiometabolic Health Congress (@CMHC_CME)
1
7
1
18
STAT1 Dissociates Adipose Tissue Inflammation From Insulin Sensitivity in Obesity diabetes.diabetesjournals.or… @BCM_CVRI @CBallantyneMD nice work from a collaborator showing similar but not the same role of stat1 in fat cells – at Houston, TX
2
6
Deficiency of Stat1 in CD11c+ Cells Alters Adipose Tissue Inflammation and Improves Metabolic Dysfunctions in Mice Fed High-Fat Diet diabetes.diabetesjournals.or… @CBallantyneMD @BCM_CVRI @zeqin lian. a potential role of jak/stat1 pathway in macrophage inflammation with obesity. – at Houston, TX
1
2
10 days until the first Houston "Prevention Rules" CME ..register at cpd.education.bcm.edu/conten… @CBallantyneMD @virani_md @PamTaubMD
1
5
2
11
✨Excited to share our paper on 'Monocyte Phenotyping & Management of #LipoproteinX Syndrome' in-press @LipidJournal !! ✨Plasmapheresis of an #LpX pt w/ ⬆️⬆️cholesterol & xanthomas & effect on monocyte phenotype in this clinic ↔️bench approach. 👉 bit.ly/3byYjUL 1/2
Image from Anum Saeed (@AnumSaeedMD)
3
7
2
19
New research shows how Lp(a) and family history can have additive and independent associations with #CVD risk: Do you check Lp(a)? bit.ly/3fMhgDK #JACC @amehta_09 @dramitkhera @virani_md @CBallantyneMD
Image from JACC Journals (@JACCJournals)
2
18
5
53
#inflammation #obesity #metabolism ⁦@CircRes⁩ ⁦@hwubcm⁩ ⁦@BCM_CVRI⁩ ⁦@bcmhouston⁩ ⁦@BCMFromtheLabs⁩ #diabetes #CVD We have come a long way since the concept of #adipose tissue only storing #triglycerides !
Image from Christie Ballantyne (@CBallantyneMD)
10
1
30
Metabolic Inflammation and Insulin Resistance in Obesity | Circulation Research Wonderful issue ⁦@CircRes⁩ ⁦@hwubcm⁩ #obesity #inflammation #diabetes @BCMDeptMedicine⁩ ⁦@bcmhouston⁩ #macrophages #metabolism ahajournals.org/doi/10.1161/…
Metabolic Inflammation and Insulin Resistance in Obesity | Circulation Research

Metabolic Inflammation and Insulin Resistance in Obesity | Circulation Research

Obesity is becoming an epidemic in the United States and worldwide and increases risk for many diseases, particularly insulin resistance, type 2 diabetes mellitus, and cardiovascular disease. The...

ahajournals.org
9
19
Foamy Monocytes, Extra Virgin Olive Oil and Nut-Enriched Diet, and Atheroprotection | Arteriosclerosis, Thrombosis, and Vascular Biology ahajournals.org/doi/10.1161/… #diet #fattyacids #inflammation @hwubcm #triglycerides

Foamy Monocytes, Extra Virgin Olive Oil and Nut-Enriched Diet, and Atheroprotection | Arterioscle...

ahajournals.org
3
5
academic.oup.com/jcem/advanc…
1
Load more